Altered microRNAs related to synaptic function as potential plasma biomarkers for Alzheimer’s disease

BACKGROUND: Several evidences suggest that failure of synaptic function occurs at preclinical stages of Alzheimer’s disease (AD) preceding neuronal loss and the classical AD pathological hallmarks. Nowadays, there is an urgent need to identify reliable biomarkers that could be obtained with non-inva...

Descripción completa

Detalles Bibliográficos
Autores principales: Siedlecki-Wullich, Dolores, Català-Solsona, Judit, Fábregas, Cristina, Hernández, Isabel, Clarimon, Jordi, Lleó, Alberto, Boada, Merce, Saura, Carlos A., Rodríguez-Álvarez, José, Miñano-Molina, Alfredo J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521366/
https://www.ncbi.nlm.nih.gov/pubmed/31092279
http://dx.doi.org/10.1186/s13195-019-0501-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521366/
https://www.ncbi.nlm.nih.gov/pubmed/31092279
http://dx.doi.org/10.1186/s13195-019-0501-4

Ejemplares similares